Non-Opioid Pain Management Treatment in Phase One of Clinical Trial
Today (10/20) AmacaThera was granted approval from Health Canada to send their post-operative long-term anesthetic into phase one of clinical trials. This is the first drug they have sent through the clinical trial phase a milestone for the company. AmacaThera was...
Dealing with Data Challenges Associated with COVID-19 Clinical Trials
COVID-19 has disrupted the clinical trial landscape today. The situation has caused many patients not wanting to visit sites, resulting in multiple missed patient visits. The availability of sites and investigators themselves have been limited, since sites have been...
Clinical Trials During COVID-19: A Glimpse into a Healthier World
While COVID-19 has caused many interruptions across industries, the drug development and supply chain has experienced some of the most severe repercussions. With potential exposure to the virus limiting number of trial participants, as well as site staff and...
Transcreation: Marketing Translations for Life Science Industries
Marketing translations is a vital step across all industries. With so many different cultures affecting global markets, it’s important to present branding messages in a way that is culturally sensitive as well as linguistically accurate for product’s or service’s...
How Technology is Enabling Patients’ Voices to be Heard in Clinical Research
COVID-19 has forced most of the world to work remotely, causing a major disruption in clinical trial research and the drug development process. As a result, the need for centralized and advanced patient engagement technology to better healthcare for all parties...
Augmented Reality and Virtual Reality in Healthcare: Opening New Possibilities for Efficient Care Delivery
Across industries, professional translation and localization services are essential to bringing innovative products to consumers across linguistic and national borders. For the healthcare industry, however, the stakes are often much higher, as the smallest...
Adapting Medical Communications in Japan
Japan has one of the world’s largest and most successful medical markets, with leading pharmaceutical companies including Eisai, Takeda, and Daiichi Sankyo, and medical device manufacturers like Terumo, NIPRO, and Hitachi Medico. As a founding member of the...
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com
